Loading insider details...
Beta
Latest Form 4 (Oct 20, 2026): Grant/Award of 12,400 MLYS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 20, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Grant/Award | 12,400 | n/a |
| Jun 10, 2026 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 32,947 | n/a |
| Nov 6, 2025 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 207,931 | n/a |
| Jun 28, 2024 | Verve Therapeutics, Inc. (VERV) | Grant/Award | 136,139 | n/a |
| Jun 14, 2024 | Blueprint Medicines Corp (BPMC) | Grant/Award | 2,242 | n/a |
| Feb 29, 2024 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Exercise/Conversion | 33,333 | n/a |
| Feb 12, 2024 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 770,420 | n/a |
| Nov 17, 2023 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Purchase | 90,000 | $94.8K |
| Nov 13, 2023 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Purchase | 10,000 | $10.1K |
| Jun 29, 2023 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Purchase | 10,000 | $21.6K |